United States: Site-Neutral Hospitals Find Reprieve For Their Outpatient Departments Through The Courts

Last Updated: October 1 2019
Article by Lawrence W. Vernaglia and Adria E. Warren

On September 17, 2019, the D.C. District Court held that the Centers for Medicare & Medicaid Services (CMS) exceeded its statutory authority when it cut the payment rate for clinic services at off-campus provider-based departments (OCODPs). The hospital industry has every right to be pleased with this decision that granted summary judgment in favor of the American Hospital Association, the Association of American Medical Colleges, and various hospital plaintiffs.

Although hospitals are breathing a sigh of relief, for those following the case, the outcome was not entirely unexpected. The case comes out of the same court that dealt a blow to CMS' efforts to reduce payments associated with OCODP services when it shot down the 340B drug reimbursement cuts. However, Judge Collyer's decision was a broad denouncement of CMS' approach, with potential implications to limit future selective payment reductions under the Outpatient Prospective Payment System (OPPS), and not just for OCODPs.


In November 2018, CMS issued a rule (Final Rule) designed to impose "site neutrality" for the most common outpatient hospital services delivered in OCODPs that are excepted from the current statutory site neutrality law. In adopting the Final Rule, CMS extended the payment cuts mandated in Section 603 of the Bipartisan Budget Act of 2015 (BiBA Section 603) and its implementing regulations. BiBA had significantly reduced Medicare reimbursement for OCODPs that were not already in existence (or in a "mid-build") as of November 2, 2015 unless they were "dedicated emergency departments". After that date, payment for any new OCODPs was intended to approximate what would be paid for the service if it had instead been performed in a physician office, or in CMS' rough justice, 40% of the OPPS rates. Off-campus OCODPs billing under OPPS as of November 2, 2015 were deemed "excepted" (grandfathered) for purposes of BiBA 603, and insulated from the rate reductions.

Notwithstanding BiBA 603, CMS remained concerned over the continuing high rate of growth of OCODP volume. On July 25, 2018, CMS proposed to implement a method for controlling perceived increases in the volume of covered outpatient services by capping the Medicare OPPS rate for clinic visit services furnished by any off-campus OCODP, whether or not it was excepted (grandfathered) under BiBA 603. Under the proposed rule, such services would effectively be reimbursed on a site-neutral basis, at rates that were functionally equivalent to physician office/off-campus rates. 

CMS received almost 3,000 comments on the proposed rule, many of which argued that CMS lacked statutory authority to implement the rate reduction. Nonetheless, on November 21, 2018, CMS issued the Final Rule implementing the proposed reimbursement change, effective January 1, 2019.

The Court's Analysis

In reaching her decision, Judge Collyer found that CMS exceeded its authority when it proposed to implement its new reimbursement approach in a non-budget neutral manner as required by statute, by seeking to characterize the new rates as a change in methodology

By statute, adjustments under the OPPS must be made in a budget neutral manner, i.e., so that the estimated amount of expenditures for the year would not be expected to vary from the estimated amount had the adjustments not been made. In adopting the Final Rule, however, CMS adopted a convenient, if self-serving, position that the reimbursement changes referred to a method for controlling increases in the volume of covered OCODP services, rather than an adjustment that would be limited by the budget neutrality provisions of the Social Security Act.

As we reported in our earlier analysis, CMS implemented its proposed method in a non-budget neutral manner based on this argument. The court disagreed with this interpretation, and found that CMS had overstepped its authority by "shoehorning" its approach into a multi-faceted, well-developed payment scheme adopted by Congress.


The ruling is far better for the hospital industry than if the court had narrowly ruled on BiBA 603 statutory impact for the 2019 reimbursement changes. This will apply to limit future selective payment reductions under OPPS, and not just to OCODPs.

The court did not need to address one other compelling argument raised by the plaintiffs. In adopting BIBA 603, Congress had drawn a line in the sand around those that had been billing OPPS prior to November 2, 2015. The Final Rule ignored that distinction, and erased a significant portion of the benefits of the excepted (grandfathered) locations. In so doing, CMS was effectively overriding the negotiated final word of Congress. We expected that this would offend the courts. However, and importantly, this was not the basis for the Court's decision. Rather, the court ruled more broadly, focusing on the core powers of CMS to make reimbursement changes under the OPPS system. 

Ultimately, in the court's view, changes needed to be across the board (through changes to the OPPS adjustment factor) or budget neutral (where a payment reduction on one APC would be offset by an increase on another). CMS, the Court ruled, did neither, and, therefore, its 2019 payment reduction was beyond their power ("ultra vires"). 

As for remedies, the Court did not order CMS to start writing checks to hospitals. Rather, it is requiring the parties provide a joint status report by October 1, 2019. On September 23, CMS filed a motion requesting that the court remand the case without vacating the challenged portion of the Final Rule, or, alternatively, that the court stay proceedings for sixty days while the government considers an appeal. 

Bottom line, it may be a while before hospitals get their money back, or even start being paid correctly for current services. CMS has 60 days to file an appeal once the judgment is entered (which as of the date of this writing has not yet happened, as noted above). Assuming CMS appeals this decision (as it did in the 340B case, referenced above) it might be quite a while before hospitals see their reimbursements restored.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions